Recently, Bristol-Myers Squibb Company (BMY) and partner, Pfizer Inc. (PFE) received some encouraging news with the European Medicines Agency's (:EMA) Committee for Medicinal Products for Human Use ...
Zacks Investment Research on MSN
Will the recent pricing deal with the government impact BMY's sales?
Bristol Myers Squibb BMY announced a pricing agreement with the U.S. government to supply Eliquis (apixaban) at no cost to Medicaid beginning Jan. 1, 2026. BMY will also donate more than 7 tons of the ...
The US approval process of Bristol-Myers Squibb Company/Pfizer Inc.’s (BMY/PFE) anti-clotting drug Eliquis (apixaban) is back on track with the US Food and Drug Administration (:FDA) accepting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback